The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global NK Cell Therapy Market Research Report 2025
Synopsis
The global market for NK Cell Therapy was valued at US$ 469 million in the year 2024 and is projected to reach a revised size of US$ 1322 million by 2031, growing at a CAGR of 16.2% during the forecast period.
Cell therapy, a new therapeutic approach that uses a patient"s own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body"s first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
North America is the largest NK Cell Therapy market with about 51% market share. Europe is follower, accounting for about 33% market share.The key manufacturers are Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics, Fortress Biotech etc. Top 3 companies occupied about 82% market share.
This report aims to provide a comprehensive presentation of the global market for NK Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NK Cell Therapy.
The NK Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global NK Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NK Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Fate Therapeutics
Glycostem Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
NantWorks
Nkarta Therapeutics
Fortress Biotech
Segment by Type
NK Cell Therapies
NK Cell Directed Antibodies
Segment by Application
Cancer
Gastrointestinal Diseases
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NK Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global market for NK Cell Therapy was valued at US$ 469 million in the year 2024 and is projected to reach a revised size of US$ 1322 million by 2031, growing at a CAGR of 16.2% during the forecast period.
Cell therapy, a new therapeutic approach that uses a patient"s own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body"s first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
North America is the largest NK Cell Therapy market with about 51% market share. Europe is follower, accounting for about 33% market share.The key manufacturers are Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics, Fortress Biotech etc. Top 3 companies occupied about 82% market share.
This report aims to provide a comprehensive presentation of the global market for NK Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NK Cell Therapy.
The NK Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global NK Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NK Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Fate Therapeutics
Glycostem Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
NantWorks
Nkarta Therapeutics
Fortress Biotech
Segment by Type
NK Cell Therapies
NK Cell Directed Antibodies
Segment by Application
Cancer
Gastrointestinal Diseases
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NK Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NK Cell Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 NK Cell Therapies
1.2.3 NK Cell Directed Antibodies
1.3 Market by Application
1.3.1 Global NK Cell Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer
1.3.3 Gastrointestinal Diseases
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global NK Cell Therapy Market Perspective (2020-2031)
2.2 Global NK Cell Therapy Growth Trends by Region
2.2.1 Global NK Cell Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 NK Cell Therapy Historic Market Size by Region (2020-2025)
2.2.3 NK Cell Therapy Forecasted Market Size by Region (2026-2031)
2.3 NK Cell Therapy Market Dynamics
2.3.1 NK Cell Therapy Industry Trends
2.3.2 NK Cell Therapy Market Drivers
2.3.3 NK Cell Therapy Market Challenges
2.3.4 NK Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NK Cell Therapy Players by Revenue
3.1.1 Global Top NK Cell Therapy Players by Revenue (2020-2025)
3.1.2 Global NK Cell Therapy Revenue Market Share by Players (2020-2025)
3.2 Global NK Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by NK Cell Therapy Revenue
3.4 Global NK Cell Therapy Market Concentration Ratio
3.4.1 Global NK Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NK Cell Therapy Revenue in 2024
3.5 Global Key Players of NK Cell Therapy Head office and Area Served
3.6 Global Key Players of NK Cell Therapy, Product and Application
3.7 Global Key Players of NK Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 NK Cell Therapy Breakdown Data by Type
4.1 Global NK Cell Therapy Historic Market Size by Type (2020-2025)
4.2 Global NK Cell Therapy Forecasted Market Size by Type (2026-2031)
5 NK Cell Therapy Breakdown Data by Application
5.1 Global NK Cell Therapy Historic Market Size by Application (2020-2025)
5.2 Global NK Cell Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America NK Cell Therapy Market Size (2020-2031)
6.2 North America NK Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America NK Cell Therapy Market Size by Country (2020-2025)
6.4 North America NK Cell Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe NK Cell Therapy Market Size (2020-2031)
7.2 Europe NK Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe NK Cell Therapy Market Size by Country (2020-2025)
7.4 Europe NK Cell Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NK Cell Therapy Market Size (2020-2031)
8.2 Asia-Pacific NK Cell Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific NK Cell Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific NK Cell Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America NK Cell Therapy Market Size (2020-2031)
9.2 Latin America NK Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America NK Cell Therapy Market Size by Country (2020-2025)
9.4 Latin America NK Cell Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NK Cell Therapy Market Size (2020-2031)
10.2 Middle East & Africa NK Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa NK Cell Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa NK Cell Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Nektar Therapeutics
11.1.1 Nektar Therapeutics Company Details
11.1.2 Nektar Therapeutics Business Overview
11.1.3 Nektar Therapeutics NK Cell Therapy Introduction
11.1.4 Nektar Therapeutics Revenue in NK Cell Therapy Business (2020-2025)
11.1.5 Nektar Therapeutics Recent Development
11.2 Innate Pharma SA
11.2.1 Innate Pharma SA Company Details
11.2.2 Innate Pharma SA Business Overview
11.2.3 Innate Pharma SA NK Cell Therapy Introduction
11.2.4 Innate Pharma SA Revenue in NK Cell Therapy Business (2020-2025)
11.2.5 Innate Pharma SA Recent Development
11.3 Affimed
11.3.1 Affimed Company Details
11.3.2 Affimed Business Overview
11.3.3 Affimed NK Cell Therapy Introduction
11.3.4 Affimed Revenue in NK Cell Therapy Business (2020-2025)
11.3.5 Affimed Recent Development
11.4 Chipscreen Biosciences
11.4.1 Chipscreen Biosciences Company Details
11.4.2 Chipscreen Biosciences Business Overview
11.4.3 Chipscreen Biosciences NK Cell Therapy Introduction
11.4.4 Chipscreen Biosciences Revenue in NK Cell Therapy Business (2020-2025)
11.4.5 Chipscreen Biosciences Recent Development
11.5 Fate Therapeutics
11.5.1 Fate Therapeutics Company Details
11.5.2 Fate Therapeutics Business Overview
11.5.3 Fate Therapeutics NK Cell Therapy Introduction
11.5.4 Fate Therapeutics Revenue in NK Cell Therapy Business (2020-2025)
11.5.5 Fate Therapeutics Recent Development
11.6 Glycostem Therapeutics
11.6.1 Glycostem Therapeutics Company Details
11.6.2 Glycostem Therapeutics Business Overview
11.6.3 Glycostem Therapeutics NK Cell Therapy Introduction
11.6.4 Glycostem Therapeutics Revenue in NK Cell Therapy Business (2020-2025)
11.6.5 Glycostem Therapeutics Recent Development
11.7 Dragonfly Therapeutics
11.7.1 Dragonfly Therapeutics Company Details
11.7.2 Dragonfly Therapeutics Business Overview
11.7.3 Dragonfly Therapeutics NK Cell Therapy Introduction
11.7.4 Dragonfly Therapeutics Revenue in NK Cell Therapy Business (2020-2025)
11.7.5 Dragonfly Therapeutics Recent Development
11.8 Kiadis Pharma
11.8.1 Kiadis Pharma Company Details
11.8.2 Kiadis Pharma Business Overview
11.8.3 Kiadis Pharma NK Cell Therapy Introduction
11.8.4 Kiadis Pharma Revenue in NK Cell Therapy Business (2020-2025)
11.8.5 Kiadis Pharma Recent Development
11.9 NantWorks
11.9.1 NantWorks Company Details
11.9.2 NantWorks Business Overview
11.9.3 NantWorks NK Cell Therapy Introduction
11.9.4 NantWorks Revenue in NK Cell Therapy Business (2020-2025)
11.9.5 NantWorks Recent Development
11.10 Nkarta Therapeutics
11.10.1 Nkarta Therapeutics Company Details
11.10.2 Nkarta Therapeutics Business Overview
11.10.3 Nkarta Therapeutics NK Cell Therapy Introduction
11.10.4 Nkarta Therapeutics Revenue in NK Cell Therapy Business (2020-2025)
11.10.5 Nkarta Therapeutics Recent Development
11.11 Fortress Biotech
11.11.1 Fortress Biotech Company Details
11.11.2 Fortress Biotech Business Overview
11.11.3 Fortress Biotech NK Cell Therapy Introduction
11.11.4 Fortress Biotech Revenue in NK Cell Therapy Business (2020-2025)
11.11.5 Fortress Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global NK Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of NK Cell Therapies
Table 3. Key Players of NK Cell Directed Antibodies
Table 4. Global NK Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global NK Cell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global NK Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global NK Cell Therapy Market Share by Region (2020-2025)
Table 8. Global NK Cell Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global NK Cell Therapy Market Share by Region (2026-2031)
Table 10. NK Cell Therapy Market Trends
Table 11. NK Cell Therapy Market Drivers
Table 12. NK Cell Therapy Market Challenges
Table 13. NK Cell Therapy Market Restraints
Table 14. Global NK Cell Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global NK Cell Therapy Market Share by Players (2020-2025)
Table 16. Global Top NK Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NK Cell Therapy as of 2024)
Table 17. Ranking of Global Top NK Cell Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by NK Cell Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of NK Cell Therapy, Headquarters and Area Served
Table 20. Global Key Players of NK Cell Therapy, Product and Application
Table 21. Global Key Players of NK Cell Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global NK Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global NK Cell Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global NK Cell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global NK Cell Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global NK Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global NK Cell Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global NK Cell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global NK Cell Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America NK Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America NK Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America NK Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe NK Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe NK Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe NK Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific NK Cell Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific NK Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific NK Cell Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America NK Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America NK Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America NK Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa NK Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa NK Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa NK Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Nektar Therapeutics Company Details
Table 47. Nektar Therapeutics Business Overview
Table 48. Nektar Therapeutics NK Cell Therapy Product
Table 49. Nektar Therapeutics Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 50. Nektar Therapeutics Recent Development
Table 51. Innate Pharma SA Company Details
Table 52. Innate Pharma SA Business Overview
Table 53. Innate Pharma SA NK Cell Therapy Product
Table 54. Innate Pharma SA Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 55. Innate Pharma SA Recent Development
Table 56. Affimed Company Details
Table 57. Affimed Business Overview
Table 58. Affimed NK Cell Therapy Product
Table 59. Affimed Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 60. Affimed Recent Development
Table 61. Chipscreen Biosciences Company Details
Table 62. Chipscreen Biosciences Business Overview
Table 63. Chipscreen Biosciences NK Cell Therapy Product
Table 64. Chipscreen Biosciences Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 65. Chipscreen Biosciences Recent Development
Table 66. Fate Therapeutics Company Details
Table 67. Fate Therapeutics Business Overview
Table 68. Fate Therapeutics NK Cell Therapy Product
Table 69. Fate Therapeutics Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 70. Fate Therapeutics Recent Development
Table 71. Glycostem Therapeutics Company Details
Table 72. Glycostem Therapeutics Business Overview
Table 73. Glycostem Therapeutics NK Cell Therapy Product
Table 74. Glycostem Therapeutics Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 75. Glycostem Therapeutics Recent Development
Table 76. Dragonfly Therapeutics Company Details
Table 77. Dragonfly Therapeutics Business Overview
Table 78. Dragonfly Therapeutics NK Cell Therapy Product
Table 79. Dragonfly Therapeutics Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 80. Dragonfly Therapeutics Recent Development
Table 81. Kiadis Pharma Company Details
Table 82. Kiadis Pharma Business Overview
Table 83. Kiadis Pharma NK Cell Therapy Product
Table 84. Kiadis Pharma Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 85. Kiadis Pharma Recent Development
Table 86. NantWorks Company Details
Table 87. NantWorks Business Overview
Table 88. NantWorks NK Cell Therapy Product
Table 89. NantWorks Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 90. NantWorks Recent Development
Table 91. Nkarta Therapeutics Company Details
Table 92. Nkarta Therapeutics Business Overview
Table 93. Nkarta Therapeutics NK Cell Therapy Product
Table 94. Nkarta Therapeutics Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 95. Nkarta Therapeutics Recent Development
Table 96. Fortress Biotech Company Details
Table 97. Fortress Biotech Business Overview
Table 98. Fortress Biotech NK Cell Therapy Product
Table 99. Fortress Biotech Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 100. Fortress Biotech Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. NK Cell Therapy Picture
Figure 2. Global NK Cell Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global NK Cell Therapy Market Share by Type: 2024 VS 2031
Figure 4. NK Cell Therapies Features
Figure 5. NK Cell Directed Antibodies Features
Figure 6. Global NK Cell Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global NK Cell Therapy Market Share by Application: 2024 VS 2031
Figure 8. Cancer Case Studies
Figure 9. Gastrointestinal Diseases Case Studies
Figure 10. Others Case Studies
Figure 11. NK Cell Therapy Report Years Considered
Figure 12. Global NK Cell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global NK Cell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global NK Cell Therapy Market Share by Region: 2024 VS 2031
Figure 15. Global NK Cell Therapy Market Share by Players in 2024
Figure 16. Global Top NK Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NK Cell Therapy as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by NK Cell Therapy Revenue in 2024
Figure 18. North America NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America NK Cell Therapy Market Share by Country (2020-2031)
Figure 20. United States NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe NK Cell Therapy Market Share by Country (2020-2031)
Figure 24. Germany NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific NK Cell Therapy Market Share by Region (2020-2031)
Figure 32. China NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America NK Cell Therapy Market Share by Country (2020-2031)
Figure 40. Mexico NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa NK Cell Therapy Market Share by Country (2020-2031)
Figure 44. Turkey NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Nektar Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 48. Innate Pharma SA Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 49. Affimed Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 50. Chipscreen Biosciences Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 51. Fate Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 52. Glycostem Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 53. Dragonfly Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 54. Kiadis Pharma Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 55. NantWorks Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 56. Nkarta Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 57. Fortress Biotech Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
